134 related articles for article (PubMed ID: 1690065)
1. [Effect of human recombinant erythropoietin therapy on protein metabolism of patients with terminal renal failure on hemodialysis].
Scigalla P; Fischer C; Park W; Becker H; Schiller R; Paust H; Brösicke H; Kessel M
Beitr Infusionsther; 1990; 25():430-8. PubMed ID: 1690065
[No Abstract] [Full Text] [Related]
2. [Ergometric results of r-erythropoietin treatment of hemodialysis patients].
Hortian B; Schmidt R; Wüstenberg PW; Dörp E; Schumann L; Winkler R; Klinkmann H
Z Gesamte Inn Med; 1990 May; 45(10):274-7. PubMed ID: 2392856
[TBL] [Abstract][Full Text] [Related]
3. [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients].
Ueyama H; Nakahashi H; Sawanishi K; Kuze M; Ono T
Hinyokika Kiyo; 1992 Dec; 38(12):1429-35. PubMed ID: 1288237
[TBL] [Abstract][Full Text] [Related]
4. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
[TBL] [Abstract][Full Text] [Related]
5. Effect of low dose recombinant human omega erythropoietin (rHuEPO) on anaemia in patients on hemodialysis.
Acharya VN; Sinha DK; Almeida AF; Pathare AV
J Assoc Physicians India; 1995 Aug; 43(8):539-42. PubMed ID: 8772973
[TBL] [Abstract][Full Text] [Related]
6. [Use of erythropoietin in patients with chronic renal insufficiency and in hemodialysis].
Cuero CJ; Pérez Guardia E; de Rivera C
Rev Med Panama; 1996; 21(1-2):55-9. PubMed ID: 8966240
[TBL] [Abstract][Full Text] [Related]
7. [The effect of correcting anemia with recombinant erythropoietin on the central hemodynamic indices of patients on regular hemodialysis].
Ermolenko VM; Khvoĭnitskiĭ VA; Suprun EK; Tsukerman LI; Pokrovskiĭ IuA
Ter Arkh; 1992; 64(7):86-8. PubMed ID: 1440377
[No Abstract] [Full Text] [Related]
8. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
Zehnder C; Blumberg A
Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
[TBL] [Abstract][Full Text] [Related]
9. [The efficacy of an erythropoietin-calcitriol combination in patients with chronic kidney failure on programmed hemodialysis].
Nikolaev AIu; Klepikov PV; Lashutin SV; Kukhtevich AV
Ter Arkh; 1995; 67(5):27-31. PubMed ID: 7638771
[TBL] [Abstract][Full Text] [Related]
10. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
Nissenson AR
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
[TBL] [Abstract][Full Text] [Related]
11. [Cutaneous reactions to treatment with recombinant human erythropoietin].
Schröder-Kolb B
Derm Beruf Umwelt; 1990; 38(1):12-3. PubMed ID: 2139602
[TBL] [Abstract][Full Text] [Related]
12. [Human recombinant erythropoietin in the treatment of anemia in patients on long-term hemodialysis].
Boratyńska M; Szewczyk Z; Szepietowski T; Czyz W; Cybulski K; Bogucki J; Szczepański J
Przegl Lek; 1990; 47(11):741-5. PubMed ID: 2098840
[TBL] [Abstract][Full Text] [Related]
13. Monitoring erythropoietin therapy for anaemia of chronic renal failure by serum erythropoietin assays.
Marsden JT; Sherwood RA; Hillis A; Peters TJ
Ann Clin Biochem; 1993 Mar; 30 ( Pt 2)():205-6. PubMed ID: 8466156
[No Abstract] [Full Text] [Related]
14. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
[TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.
Altun B; Erdem Y; Haznedaroğlu I; Gürsoy M; Yasavul U; Turgan C; Cağlar S; Kirazli S
Nephrol Dial Transplant; 1995 Nov; 10(11):2164. PubMed ID: 8643199
[No Abstract] [Full Text] [Related]
16. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N
Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
[TBL] [Abstract][Full Text] [Related]
17. Correction of amino acid metabolism by recombinant human erythropoietin therapy in hemodialysis patients.
Riedel E; Hampl H; Scigalla P; Nündel M; Kessel M
Kidney Int Suppl; 1989 Nov; 27():S216-21. PubMed ID: 2636662
[TBL] [Abstract][Full Text] [Related]
18. [Use of recombinant erythropoietin on secondary anemia in patients in the terminal phase of renal insufficiency on hemodialysis].
Gasparović V; Puretić Z; Vrhovac B; Gjurasin M; Puljević D
Acta Med Iugosl; 1990; 44(2):129-35. PubMed ID: 2353593
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin can be administered during dialysis. A kinetic analysis.
Petersen J; Kang MS; Hays MT
ASAIO J; 1996; 42(1):27-33. PubMed ID: 8808454
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo.
Hino M; Miyazono K; Urabe A; Takaku F
Int J Cell Cloning; 1989 Jul; 7(4):257-63. PubMed ID: 2768843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
